Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 24% ± 6% | |
epithelial cell | 7 studies | 36% ± 18% | |
basal cell | 6 studies | 29% ± 10% | |
fibroblast | 6 studies | 21% ± 6% | |
oligodendrocyte | 6 studies | 27% ± 8% | |
adipocyte | 5 studies | 21% ± 3% | |
macrophage | 5 studies | 20% ± 2% | |
pericyte | 4 studies | 20% ± 5% | |
smooth muscle cell | 4 studies | 17% ± 2% | |
abnormal cell | 4 studies | 20% ± 6% | |
interneuron | 4 studies | 34% ± 22% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 8% | |
CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
conventional dendritic cell | 3 studies | 27% ± 7% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
neural crest cell | 3 studies | 17% ± 2% | |
microglial cell | 3 studies | 21% ± 4% | |
myofibroblast cell | 3 studies | 18% ± 1% | |
myeloid cell | 3 studies | 20% ± 5% | |
ciliated cell | 3 studies | 32% ± 5% | |
dendritic cell | 3 studies | 31% ± 8% | |
glutamatergic neuron | 3 studies | 44% ± 21% | |
neuron | 3 studies | 33% ± 12% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 4% | |
astrocyte | 3 studies | 36% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 690.30 | 1445 / 1445 | 100% | 13.28 | 183 / 183 |
ovary | 100% | 1185.73 | 180 / 180 | 100% | 21.25 | 430 / 430 |
pancreas | 100% | 1065.07 | 328 / 328 | 100% | 9.73 | 178 / 178 |
breast | 100% | 1026.16 | 459 / 459 | 100% | 17.75 | 1117 / 1118 |
lung | 100% | 628.45 | 576 / 578 | 100% | 12.10 | 1154 / 1155 |
brain | 100% | 656.27 | 2632 / 2642 | 100% | 10.17 | 703 / 705 |
prostate | 100% | 734.36 | 245 / 245 | 99% | 11.22 | 497 / 502 |
thymus | 100% | 853.40 | 653 / 653 | 99% | 14.10 | 598 / 605 |
bladder | 100% | 891.52 | 21 / 21 | 98% | 11.99 | 496 / 504 |
uterus | 100% | 908.72 | 170 / 170 | 98% | 11.74 | 451 / 459 |
stomach | 100% | 771.66 | 359 / 359 | 98% | 12.71 | 281 / 286 |
intestine | 100% | 776.20 | 966 / 966 | 97% | 12.99 | 512 / 527 |
kidney | 100% | 815.11 | 89 / 89 | 95% | 9.04 | 859 / 901 |
liver | 98% | 376.28 | 222 / 226 | 96% | 9.08 | 388 / 406 |
skin | 100% | 937.50 | 1809 / 1809 | 92% | 9.39 | 436 / 472 |
adrenal gland | 100% | 767.85 | 258 / 258 | 90% | 6.87 | 206 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.83 | 29 / 29 |
muscle | 100% | 1543.42 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 449.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.06 | 1 / 1 |
blood vessel | 100% | 822.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 930.90 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 655.31 | 814 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 13.96 | 75 / 80 |
peripheral blood | 26% | 347.79 | 238 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006259 | Biological process | DNA metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0008296 | Molecular function | 3'-5'-DNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TATDN1 |
Protein name | Deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein) TatD DNase domain containing 1 Deoxyribonuclease TATDN1 |
Synonyms | CDA11 hCG_1780029 |
Description | FUNCTION: Deoxyribonuclease which catalyzes (in vitro) the decatenation of kinetoplast DNA, which are circular DNA catenated to each other, producing linear DNA molecules (By similarity). Plays an important role in chromosomal segregation and cell cycle progression during eye development probably via its DNA decatenation activity (By similarity). . |
Accessions | ENST00000523214.5 ENST00000520321.5 ENST00000519548.5 [Q6P1N9-2] ENST00000520938.3 ENST00000523888.5 G5EA19 U3KQS5 E5RI69 ENST00000522927.5 ENST00000276692.11 [Q6P1N9-1] Q6P1N9 ENST00000708482.1 [Q6P1N9-2] ENST00000605953.5 ENST00000519776.5 E5RH86 H0YBX2 ENST00000708478.1 [Q6P1N9-1] ENST00000630259.1 E5RGF2 ENST00000523152.3 ENST00000517678.5 E5RG62 ENST00000522310.5 ENST00000519232.5 E5RG17 E5RJY6 E5RK70 E5RID7 A0A0D9SGD3 ENST00000522810.5 |